Major DepressionMDDNCT07807735
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD)
A study testing Virtual reality in people with Major Depression, run by Edward Via Virginia College of Osteopathic Medicine at 1 site in United States.
Trial summary
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. Read more about this study
- Who is it for?
- Ages 13 to 17 years
- Conditions the study is for
- Major Depression
- What is being tested?
- Virtual reality
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2026to Jan 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- -
Who cannot join
- A patient that has been started on an antidepressant medication within the last 8 weeks.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
James Mahaney, PHD contact
United States1 site
Auroura Counseling
Washington, Iowa, 52353
Lindsey Van Duyn, DO, 3193334354, support@immersivemedicaltherapy.com
James Mahaney, PhD, jmahaney@vt.vcom.edu
About this study
Official title: Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression.
Read the detailed description
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. The Program Enrolls Children With Diagnosis of Major Depressive Disorder, Through Use of Virtual Reality and Education, We Are Measuring Effectiveness of the Program Through Use of PHQ9-A and GAD7. (MDD)
- Conditions
- Major Depression
- Being tested
- Virtual reality
- Keywords
- major depression, virtual reality, adolescent
- Medical subject headings
- Depressive Disorder, Major
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual realityBehavioural
Also called Educational platform
We will use a combination of virtual reality experiences and educational experiences.
| Study group | Role | What they receive |
|---|---|---|
| 10 adolescents with diagnosis of depression | Experimental | This is a single arm study for effectiveness. 10 adolescents will be enrolled in first study. Receives: Behavioral: Virtual reality |
What is being measured
The primary outcome is the main question the study is designed to answer.
Virtual Reality use helps teens with depression
Using PHQ9 scores, does this program help improve their depression scores?
Measured: 8 weeks
Virtual Reality use helps teens with anxiety
Using GAD7 scores, does this program help improve their anxiety scores?
Measured: 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Sep 2026
- Study startSep 2026 (estimated)
- Primary completionDec 2026 (estimated)
- Study completionJan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Major DepressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- 10 adolescents with diagnosis of Major Depressive Disorder will be enrolled to participate in the study. The pilot study is designed to measure effectiveness of the program.
- Masking
- None (open label)
- Enrolment
- 10 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Edward Via Virginia College of Osteopathic Medicine
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Lindsey Van Duyn, DO, Principal investigator, Edward Via College of Osteopathic Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07807735
- Sponsor's protocol ID
- 2270964
- Acronym
- MDD
- Status last verified
- Sep 2026
- First submitted
- 2 Sep 2026
- Last updated
- 8 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression
- ClinicalTrials.gov ID
- NCT07807735
- Acronym / sponsor ID
- MDD / 2270964
- Conditions
- Major Depression
- Keywords
- major depression, virtual reality, adolescent
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 10 participants (estimated)
- Lead sponsor
- Edward Via Virginia College of Osteopathic MedicineUniversity, hospital or other
- Study start
- Sep 2026 (estimated)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Jan 2027 (estimated)
- First posted
- 8 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression.
Detailed description
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. The Program Enrolls Children With Diagnosis of Major Depressive Disorder, Through Use of Virtual Reality and Education, We Are Measuring Effectiveness of the Program Through Use of PHQ9-A and GAD7. (MDD)
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- 10 adolescents with diagnosis of Major Depressive Disorder will be enrolled to participate in the study. The pilot study is designed to measure effectiveness of the program.
| Arm | Type | Receives |
|---|---|---|
| 10 adolescents with diagnosis of depression | Experimental | Behavioral: Virtual realityThis is a single arm study for effectiveness. 10 adolescents will be enrolled in first study. |
Who may qualify
- Ages
- 13 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- -
Key exclusion criteria (1 listed)
- A patient that has been started on an antidepressant medication within the last 8 weeks.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual realityAlso: Educational platformWe will use a combination of virtual reality experiences and educational experiences. | Behavioural | 10 adolescents with diagnosis of depression |
Primary outcome
Virtual Reality use helps teens with depression
Time frame: 8 weeks
Using PHQ9 scores, does this program help improve their depression scores?
Virtual Reality use helps teens with anxiety
Time frame: 8 weeks
Using GAD7 scores, does this program help improve their anxiety scores?
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2026.
Related trials for Major Depression
RecruitingPhase 3
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Recruiting
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
Major Depressive Disorder (MDD), Treatment Resistant Depression
Recruiting
Defining Neurobiological Links Between Substance Use and Mental Illness
Major Depressive Disorder, Substance Use Disorder
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Depressive Disorder, Major
RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
James Mahaney, PHD contact
Lindsey Van Duyn, DO principal investigator
Edward Via College of Osteopathic Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual reality in people with Major Depression, run by Edward Via Virginia College of Osteopathic Medicine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Lindsey Van Duyn, DO (3193334354, support@immersivemedicaltherapy.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Virtual Reality use helps teens with depression (time frame: 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026.